BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22785528)

  • 1. 18F-FDG PET detection of unknown primary malignancy in dermatomyositis.
    Mahmood S; Rodríguez Martínez de Llano S
    Clin Nucl Med; 2012 Aug; 37(8):e204-5. PubMed ID: 22785528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatomyositis in a Patient with Cholangiocarcinoma Detected by an [(18)F]-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scan.
    Suh KJ; Park JK; Cho S; Park H; Baek HW; Lee K; Lee DS; Lee KH
    Cancer Res Treat; 2016 Apr; 48(2):848-52. PubMed ID: 25797574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis.
    Tanaka S; Ikeda K; Uchiyama K; Iwamoto T; Sanayama Y; Okubo A; Nakagomi D; Takahashi K; Yokota M; Suto A; Suzuki K; Nakajima H
    Rheumatology (Oxford); 2013 Jul; 52(7):1271-8. PubMed ID: 23479721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up.
    Yapar Z; Kibar M; Yapar AF; Paydas S; Reyhan M; Kara O; Buyukdereli G; Aydin M; Kelle AP; Unal I; Disel U; Yavuz S; Sahin B; Erkisi M
    Nucl Med Commun; 2010 Jan; 31(1):59-66. PubMed ID: 19952921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of
    Motegi SI; Fujiwara C; Sekiguchi A; Hara K; Yamaguchi K; Maeno T; Higuchi T; Hirasawa H; Kodaira S; Tomonaga H; Tsushima Y; Ishikawa O
    J Dermatol; 2019 Mar; 46(3):213-218. PubMed ID: 30614031
    [No Abstract]   [Full Text] [Related]  

  • 6. 18-F fluorodeoxyglucose positron emission tomography indicating unsuspected infections in two patients with dermatomyositis.
    Bachmeyer C; Kerrou K; Chosidow O; Frances C; Montravers F
    Clin Exp Dermatol; 2009 Dec; 34(8):e769-71. PubMed ID: 20055842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG PET/CT Findings of a Small Cell Carcinoma of the Lung Presented as Diffuse Dermatomyositis.
    Li X; Tian B; Bai X
    Clin Nucl Med; 2024 Apr; 49(4):379-380. PubMed ID: 38427959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of survival and evaluation of diagnostic accuracy whole body 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the detection carcinoma of unknown primary origin.
    Tamam MO; Mulazimoglu M; Guveli TK; Tamam C; Eker O; Ozpacaci T
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2120-30. PubMed ID: 23280029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
    Kumar R; Hawkins RA; Yeh BM; Wang ZJ
    Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
    Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis.
    Owada T; Maezawa R; Kurasawa K; Okada H; Arai S; Fukuda T
    J Rheumatol; 2012 Aug; 39(8):1659-65. PubMed ID: 22753657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT useful for the early detection of rapidly progressive fatal interstitial lung disease in dermatomyositis.
    Morita Y; Kuwagata S; Kato N; Tsujimura Y; Mizutani H; Suehiro M; Isono M
    Intern Med; 2012; 51(12):1613-8. PubMed ID: 22728501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin.
    Ambrosini V; Nanni C; Rubello D; Moretti A; Battista G; Castellucci P; Farsad M; Rampin L; Fiorentini G; Franchi R; Canini R; Fanti S
    Radiol Med; 2006 Dec; 111(8):1146-55. PubMed ID: 17171520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional testing following screening strategies for occult malignancy diagnosis in patients with unprovoked venous thromboembolism.
    Robin P; Le Roux PY; Le Moigne E; Planquette B; Prévot-Bitot N; Roy PM; Pastre J; Merah A; Couturaud F; Le Gal G; Salaun PY
    Thromb Res; 2017 Jul; 155():6-9. PubMed ID: 28460260
    [No Abstract]   [Full Text] [Related]  

  • 15. [(18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin].
    Hu M; Li MH; Kong L; Liu NB; Yang GR; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):699-701. PubMed ID: 19173915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].
    Margery J; Milleron B; Vaylet F; Grahek D; Lebeau B; Mangiapan G; Bonardel G; de Labriolle-Vaylet C; Meignan M; Carette MF; Talbot JN; Housset B
    Rev Pneumol Clin; 2010 Oct; 66(5):313-20. PubMed ID: 21087727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG-PET imaging in Merkel cell carcinoma - value of head-to-toe scan.
    Golan H; Volkov O; Linchinsky O; Melloul M
    Nucl Med Rev Cent East Eur; 2005; 8(2):135-6. PubMed ID: 16437401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of F-18 fluorodeoxyglucose posıtron emıssıon tomography/computed ın carcınoma of unknown primary.
    Elboga U; Kervancioğlu S; Sahin E; Basibuyuk M; Celen YZ; Aktolun C
    Int J Clin Exp Pathol; 2014; 7(12):8941-6. PubMed ID: 25674269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG PET/CT detects clinically occult pancreatic cancer in a case of Von Hippel-Lindau syndrome.
    Kulkarni M; Purandare N; Zade A; Agrawal A; Shah S; Rangarajan V
    Clin Nucl Med; 2013 Jul; 38(7):e302-3. PubMed ID: 23486326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET/CT for detection of the unknown primary head and neck tumor.
    Johansen J; Petersen H; Godballe C; Loft A; Grau C
    Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):500-8. PubMed ID: 22019707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.